Pliant Therapeutics Inc (PLRX) — Cash Flow Reinvestment Rate
Latest as of June 2020:
13.72x
Pliant Therapeutics Inc (PLRX) has a Cash Flow Reinvestment Rate of 13.72x as of June 2020, reinvesting $106.61 Million (capex $286.00K plus investments $-106.32 Million) from operating cash flow of $7.77 Million. Check earnings quality score of Pliant Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
13.72x
(Capex + Investments) / Operating CF
Total Reinvested
$106.61 Million
Capex + Investments
Operating Cash Flow
$7.77 Million
USD
Capital Expenditures
$286.00K
USD
Annual Cash Flow Reinvestment Rate for Pliant Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Pliant Therapeutics Inc. For live market cap and broader valuation context, see Pliant Therapeutics Inc (PLRX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow